The elevated SIRT1 then stabilizes the hypoxia-inducible factor 1 α (HIF1α) protein through deacetylation, which subsequently promotes glycolytic metabolism and contributes to the chemoresistance observed in pancreatic cancer cells. This evidence concerns the gene HIF1A and familial pancreatic carcinoma.